Search

Displaying results 1851 - 1860 of 10000 in total
  1. Drug

    Insulin glulisine

    go.drugbank.com/drugs/DB01309
    Approved

    [L12519] These structural modifications decrease hexamer formation, stabilize insulin glulisine monomers and increase the rate of absorption and onset of action compared to human insulin.

    Products: APIDRA(100 UNITS/ML), APIDRA 100 Units/ml Solution for Injection in vial
  2. Drug

    Lactobacillus plantarum

    go.drugbank.com/drugs/DB11360
    Investigational

    Lactobacillus plantarum is a member of Lactobacillus, or lactic acid bacteria, that it is widely used in the food industry as a microbial starter and probiotic microorganism. It is considered to be one of versatile species that carry out...

    Products: Kimchi Lactobacillus 2000
  3. Drug

    Remlarsen

    go.drugbank.com/drugs/DB19131
    Investigational

    Remlarsen is under investigation in clinical trial NCT03601052 (Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids).

    Synonyms: Rna, (am-am-cm-a-cm-um-g-um-um-um-a-cm-a-a-a-um-g-g-um-cm-cm-um-a), 3'-(3-((6-((3.beta.), -cholest-5-en-3-yloxy)hexyl)oxy)-2-hydroxypropyl hydrogen phosphate), complex with rna ((2'-deoxy-2'-fluoro)u-a-g-(2'-deoxy-2'-fluoro)c-a-(2'-deoxy-2'-fluoro)c-(2'-de
  4. Drug

    Tocofersolan

    go.drugbank.com/drugs/DB11635
    Approved

    It was approved by the European Medicines Agency (EMA) in June 2009 under the market name Vedrop.

    Products: Aquasol E Tpgs Liquid 77iu/ml
  5. Drug

    Ilaprazole

    go.drugbank.com/drugs/DB11964
    Investigational

    Ilaprazole has been investigated in Helicobacter Infections.

    Products: NOLTEC 10 MG GASTRO-REZİSTAN TABLET, 7 ADET, NOLTEC 10 MG GASTRO-REZİSTAN TABLET, 28 ADET
  6. Drug

    Pemoline

    go.drugbank.com/drugs/DB01230
    ApprovedIllicitWithdrawn

    In 2005, the Food and Drug Administration (FDA) withdrew approval for pemoline. In March 2005, Abbott Laboratories (Cylert marketer) had discontinued the production of Cylert arguing economic reasons.

  7. Drug

    Polyinosinic-polycytidylic acid

    go.drugbank.com/drugs/DB16467
    Investigational

    Synonyms: POLYINOSINIC-POLYCYTIDYLIC ACID (LOW MW), POLYINOSINIC-POLYCYTIDYLIC ACID (HIGH MW)
  8. Drug

    Sulfamethoxazole

    go.drugbank.com/drugs/DB01015
    ApprovedInvestigational

    Sulfamethoxazole is a bacteriostatic sulfonamide antibiotic that interferes with folic acid synthesis in susceptible bacteria. It is generally given in combination with trimethoprim, which inhibits a sequential step in bacterial folic ac...

    Mixtures: METOPRIM 200 MG + 40 MG/5 ML SUSPANSIYON, 100 ML, Bactrim 200 mg + 40 mg/5 mL Süspansiyon
  9. Drug

    Patisiran

    go.drugbank.com/drugs/DB14582
    Approved

    Patisiran is a first in class short interfering RNA for the treatment of patients with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis . It is marketed as Onpattro which is formulated as patisiran within a liposome...

  10. Drug

    Rotavirus vaccine

    go.drugbank.com/drugs/DB10276
    ApprovedInvestigational

    Rotavirus commonly infects children and infants causing severe diarrhea and vomiting leading to potentially fatal dehydration. Two rotavirus vaccines are available for the prevention of rotavirus gastroenteritis, Rotateq and Rotarix. Rot...

    Categories: Complex MixturesProducts: ROTARİX 1,5 ML ORAL SÜSPANSİYON (1 TÜP), ROTARİX 1,5 ML ORAL SÜSPANSİYON (10 TÜP)